Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis

LS Tam, B Tomlinson, TT Chu, TK Li, EK Li - Clinical rheumatology, 2007 - Springer
Patients with rheumatoid arthritis (RA) have increased cardiovascular mortality. TNF-α is a
critical mediator of inflammation and metabolic response in patients with RA. Increased …

Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection

…, AYK Chan, PKS Chan, AR Chang, EK Li - Arthritis & …, 2004 - Wiley Online Library
Objective To compare the prevalence of abnormal Pap smears in patients with systemic
lupus erythematosus (SLE) with that in a large group of healthy controls, and to determine …

Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong

LS Tam, EK Li, SM Wong, CC Szeto - Scandinavian journal of …, 2002 - Taylor & Francis
Objective : To determine the risk factors associated with and to describe the clinical course
of tuberculosis (TB) in patients with systemic lupus erythematosus (SLE). Methods : Clinical …

Subclinical carotid atherosclerosis in patients with psoriatic arthritis

…, EK Li, B Tomlinson, TTW Chu, M Li… - Arthritis Care & …, 2008 - Wiley Online Library
Objective To examine the prevalence of subclinical atherosclerosis in patients with psoriatic
arthritis (PsA) compared with healthy controls, and to identify clinical and biologic markers …

Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity

CK Wong, PTY Wong, LS Tam, EK Li, DP Chen… - Journal of clinical …, 2010 - Springer
Introduction B lymphocyte chemoattractant (BLC/CXCL13), a CXC chemokine, is involved in
B1 and B2 cell trafficking for the activation of autoreactive T helper (Th) cells and …

Leflunomide in the treatment of rheumatoid arthritis

EK Li, LS Tam, B Tomlinson - Clinical therapeutics, 2004 - Elsevier
Background: Current drug therapies for rheumatoid arthritis (RA), including nonsteroidal anti-inflammatory
drugs and disease-modifying antirheumatic drugs, help control inflammation …

[HTML][HTML] Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis

CK Wong, DP Chen, LS Tam, EK Li, YB Yin… - Arthritis research & …, 2010 - Springer
Introduction Interleukin (IL)-27 is a novel member of the IL-6/IL-12 family cytokines that are
produced early by antigen-presenting cells in T helper (Th)1-mediated inflammation. Elevated …

Cost‐of‐illness studies in systemic lupus erythematosus: A systematic review

TY Zhu, LS Tam, EK Li - Arthritis care & research, 2011 - Wiley Online Library
Objective To summarize the state of knowledge regarding the economic burden of systemic
lupus erythematosus (SLE) and to evaluate the quality of cost‐of‐illness (COI) studies …

CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis

…, LS Tam, CK Wong, FWS Ko, T Li, T Zhu, EK Li - The Journal of …, 2010 - jrheum.org
Objective. To assess whether serum levels of CC and CXC chemokines correlate with disease
activity in patients with rheumatoid arthritis (RA), and to determine whether these effects …

The impact of flare on disease costs of patients with systemic lupus erythematosus

…, L Tam, VWY Lee, KKC Lee, EK Li - Arthritis Care & …, 2009 - Wiley Online Library
Objective To evaluate both direct and indirect costs of systemic lupus erythematosus (SLE)
patients with and without flares from a societal perspective, and to investigate the impact of …